Abstract
Acute pancreatitis is an acute sterile inflammation of the pancreas. The diagnosis is made on the basis of a distinct clinical syndrome consisting of acute onset abdominal pain radiating to the back and frequently accompanied by nausea and/or vomiting, combined with a more than threefold increase of serum amylase or lipase above the upper limit of normal. In the western world the most common causes of acute pancreatitis are alcohol abuse and gallstones [1]. The disease is characterized by the premature activation of digestive enzymes in the pancreas, followed by a massive immunological response resulting in autodigestion of the gland, local, and subsequent systemic inflammation. The incidence of the disease varies between 5–20 per 100 000 persons per year, with 10–20% of patients developing severe pancreatitis of whom up to 30% may die as a result of the development of secondary complications such as pancreatitis-associated lung injury, infectious complications or multiple organ failure (MOF) [1]. This chapter will focus on recent developments in the understanding of the pathophysiology and immunopathology of acute pancreatitis and its complications and discuss the importance of early severity prediction including the merits of various prognostic markers.
Keywords
- Acute Pancreatitis
- Chronic Pancreatitis
- Severe Acute Pancreatitis
- Pancreatic Necrosis
- Pancreatitis Severity
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Mergener K, Baillie J (1998) Acute pancreatitis. Br Med J 316: 44 48
Steer ML, Saluja AK (1993) Experimental pancreatitis: studies of the early events that lead to cell injury. In: Lian V, Go W, Dimagno EP, et al (eds) The Pancreas: Biology, Pathobiology and Disease. Raven Press, New York, pp 11–36
Steer ML (1999) Early events in acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 13: 213–225
Saluja AK, Donovan EA, Yamanaka K, Yamaguchi Y, Hofbauer B, Steer ML (1997) Ceruleininduced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 113: 304–310
Halangk W, Lerch MM, Brandt-Nedelev B, et al (2000) Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 1.06: 773–781
Van Acker GJ, Saluja AK, Bhagat L, Singh VP, Song AM, Steer ML (2002) Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity. Am J Physiol 283: G794 - G800
Witt H, Luck W, Hennies HC, et al (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25: 213–216
Norman J (1998) The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 175: 76–83
Gukovskaya AS, Gukovsky I, Zaninovic V, et al (1997) Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 100: 1853–1862
Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ (1998) Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 275: G1402 - G1414
Grisham MB (1999) NF-kappa B activation in acute pancreatitis: protective, detrimental, or inconsequential? Gastroenterology 116: 489–492
Chen X, Ji B, Han B, Ernst SA, Simeone D, Logsdon CD (2002) NF-kappa B activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 122: 448–457
Denham W, Yang J, Wang H, Botchkina G, Tracey KJ, Norman J (2000) Inhibition of p38 mitogen activate kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome. Crit Care Med 28: 2567–2572
Denham W, Fink G, Yang J, Ulrich P, Tracey KJ, Norman J (1997) Small molecule inhibition of tumor necrosis factor gene processing during acute pancreatitis prevents cytokine cascade progression and attenuates pancreatitis severity. Am Surg 63: 1045–1049
Norman JG, Fink GW, Messina J, Carter G, Franz MG (1996) Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 120: 515–521
Norman JG, Fink GW, Sexton C, Carter G (1996) Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-lbeta gene expression at steady-state and during the systemic stress induced by acute pancreatitis. J Surg Res 63: 231–236
de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC (1996) Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 83: 349–353
Osman MO, Jacobsen NO, Kristensen JU, et al (1998) IT 9302, a synthetic interleukin-10 agonist, diminishes acute lung injury in rabbits with acute necrotizing pancreatitis. Surgery 124: 584–592
Van Deventer SJ (1997) Tumour necrosis factor and Crohn’s disease. Gut 40: 443–448
Kaufmann P, Tilz GP, Lueger A, Demel U (1997) Elevated plasma levels of soluble tumor necrosis factor receptor (sTNFRp60) reflect severity of acute pancreatitis. Intensive Care Med 23: 841–848
Hughes CB, Grewal HP, Gaber LW, et al (1996) Anti-TNF alpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg 171: 274–280
Fink GW, Norman JG (1997) Specific changes in the pancreatic expression of the interleukin 1 family of genes during experimental acute pancreatitis. Cytokine 9: 1023–1027
Norman JG, Fink G, Franz M, et al (1996) Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg 223: 163–169
Rau B, Paszkowski A, Lillich S, Baumgart K, Moller P, Beger HG (2001) Differential effects of caspase-1/interleukin-lbeta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest 81: 1001–1013
Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP (1998) The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128: 127–137
Van der Poll T, van Deventer SJ (1998) The role of interleukin 6 in endotoxin-induced inflammatory responses. Prog Clin Biol Res 397: 365–377
Berney T, Gasche Y, Robert J, et al (1999) Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 18: 371–377
Lane JS, Todd KE, Gloor B, et al (2001) Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis. J Surg Res 99: 365–370
Kingsnorth AN, Galloway SW, Formela LJ (1995) Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 82: 1414–1420
Johnson CD, Kingsnorth AN, Imrie CW, et al (2001) Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 48: 62–69
Van der Poll T, Jansen PM, Montegut WJ, et al (1997) Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 158: 1971–1975
Van Laethem JL, Eskinazi R, Louis H, Rickaert F, Robberecht P, Deviere J (1998) Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 43: 408–413
Deviere J, Le Moine O, Van Laethem JL, et al (2001) Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 120: 498–505
Bhatia M, Saluja AK, Hofbauer B, Lee HS, Frossard JL, Steer ML (1998) The effects of neutrophil depletion on a completely noninvasive model of acute pancreatitis-associated lung injury. Int J Pancreatol 24: 77–83
Satoh A, Shimosegawa T, Fujita M, et al (1999) Inhibition of nuclear factor-kappa B activation improves the survival of rats with taurocholate pancreatitis. Gut 44: 253–258
Frossard JL, Saluja A, Bhagat L, et al (1999) The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 116: 694–701
Shokuhi S, Bhatia M, Christmas S, Sutton R, Neoptolemos JP, Slavin. J (2002) Levels of the chemokines growth-related oncogene alpha and epithelial neutrophil-activating protein 78 are raised in patients with severe acute pancreatitis. Br J Surg 89: 566–572
Denham W, Yang J, Fink G, Zervos EE, Carter G, Norman J (1997) Pancreatic ascites as a powerful inducer of inflammatory cytokines. The role of known vs unknown factors. Arch Surg 132: 1231–1236
Gukovskaya AS, Vaquero E, Zaninovic V, et al (2002) Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis. Gastroenterology 122: 974–984
Rau B, Paszkowski A, Esber S, et al (2001) Anti-ICAM-1 antibody modulates late onset of acinar cell apoptosis and early necrosis in taurocholate-induced experimental acute pancreatitis. Pancreas 23: 80–88
Bhatia M, Brady M, Zagorski J, et al (2000) Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant ( CINC) protects rats against acute pancreatitis associated lung injury. Gut 47: 838–844
Guice KS, Oldham KT, Johnson KJ, Kunkel RG, Morganroth ML, Ward PA (1988) Pancreatitis-induced acute lung injury. An ARDS model. Ann Surg 208: 71–77
Schmid SW, Uhl W, Friess H, Malfertheiner P, Buchler MW (1999) The role of infection in acute pancreatitis. Gut 45: 311–316
Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165: 867–903
Runkel N, Eibl G (1999) Pathogenesis of pancreatic infection. In: Buchler M (ed) Acute Pancreatitis: Novel Concepts in Biology and Therapy. Blackwell Science, Boston, pp 255–261
Luiten EJ, Hop WC, Lange JF, Bruining HA (1995) Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 222: 57–65
Bassi C, Falconi M, Valerio A, Marcucci S, Graziani R, Pederzoli P (1999) Identification of pancreatic infection. In: Buchler M (ed) Acute Pancreatitis: Novel Concepts in Biology and Therapy. Blackwell Science, Boston, pp 277–282
D’Egidio A, Schein M (2002) Surgical strategies in the treatment of pancreatic necrosis and infection. Br J Surg 78: 133–137
Nakos G, Malamou-Mitsi VD, Lachana A, et al (2002) Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 30: 1488–1494
Van Westerloo DJ, Schultz MJ, Bruno MJ, van Deventer S, van der Poll T (2002) Acute pancreatitis renders mice more susceptible to Pseudomonas pneumonia, which in turn aggravates the severity of pancreatitis. Evidence for a pathological vicious circle. ICAAC 2002 abstract book, ASM Press, Herndon, B808
Van Westerloo DJ, Weijer S, Bruno MJ, et al (2002) Acute pancreatitis impairs antibacterial host defense in abdominal sepsis in mice. ICAAC 2002 abstract book, ASM Press, Herndon, B1421
Windsor JA (2000) Search for prognostic markers for acute pancreatitis. Lancet 355: 19241925
Funbell I, Bornman P, Weakley S, Terblanche J, Marks I (1993) Obesity: an important prognostic factor in acute pancreatitis. Br J Surg 80: 484–486
Larvin M, McMahon MJ (1989) APACHE II score for assessment and monitoring of acute pancreatitis. Lancet 2: 201–205
Heat D, Imrie CW (1994) The Hong Kong criteria and severity prediction in acute pancreatitis. Int J Pancreatol 15: 1–7
Ranson H, Rifkind K, Roses D, Fink S, Eng K, Spencer F (1974) Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynaecol Obstet 139: 69–81
Munoz-Bongrand N, Panis Y, Soyer P, et al (2001) Serial computed tomography is rarely necessary in patients with acute pancreatitis: a prospective study in 102 patients. J Am Coll Surg 193: 146–152
Neoptolemos JP, Kemppainen EA, Mayer JM, et al (2000) Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 355: 1955–1960
Imrie CW (1999) Ransom, Glasgow, APACHE II systems: is the score a bore? In: Buchler M (ed) Acute Pancreatitis: Novel Concepts in Biology and Therapy. Blackwell Science, Boston, pp 199–209
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
van Westerloo, D.J., Bruno, M.J., van der Poll, T. (2003). New Insights into the Pathophysiology and Severity Assessment of Acute Pancreatitis. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-5548-0_76
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5548-0_76
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-5550-3
Online ISBN: 978-1-4757-5548-0
eBook Packages: Springer Book Archive